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FADD/MORT1 and Caspase-8 Are Recruited to TRAIL
Receptors 1 and 2 and Are Essential for Apoptosis
Mediated by TRAIL Receptor 2
signal due to the presence of a cytoplasmic death do-
main (DD) (Krammer, 1999; Peter et al., 1999).
TNF-related apoptosis-inducing ligand (TRAIL/APO-
2L) was identified by sequence homology to CD95L and
TNF (Wiley et al., 1995; Pitti et al., 1996). Interestingly,
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The functional expression of TRAIL was recently dis-
covered on the surface of different cells of the immune
Summary system previously known to induce apoptosis in target
cells by an unidentified mechanism. Among them are
Apoptosis induced by tumor necrosis factor (TNF)- type II interferon (IFN-g) ±stimulated monocytes (Griffith
related apoptosis-inducing ligand (TRAIL/APO-2L) et al., 1999b), type I IFN- (IFN-a and IFN-b) or TCR-
has been shown to exert important functions during stimulated T cells (Kayagaki et al., 1999a; Musgrave
various immunological processes. The involvement of et al., 1999), nonstimulated CD41 T cells (Mariani and
the death adaptor proteins FADD/MORT1, TRADD, and Krammer, 1998; Thomas and Hersey, 1998; Kayagaki et
RIP and the apoptosis-initiating caspases-8 and -10 al., 1999b; Martinez-Lorenzo et al., 1999), IFN-a and IFN-
in death signaling by the two death-inducing TRAIL g-stimulated as well as measles virus-infected dendritic
receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are con- cells (DC) (Fanger et al., 1999; Vidalain et al., 2000), and
troversial. Analysis of the native TRAIL death-inducing natural killer (NK) cells (Zamai et al., 1998; Johnsen et
signaling complex (DISC) revealed ligand-dependent al., 1999; Kashii et al., 1999; Kayagaki et al., 1999c).
recruitment of FADD/MORT1 and caspase-8. Differen- TRAIL interacts with five distinct receptors: TRAIL-
tial precipitation of ligand-stimulated TRAIL receptors R1 (DR4) (Pan et al., 1997b), TRAIL-R2 (DR5/TRICK2/
demonstrated that FADD/MORT1 and caspase-8 were KILLER) (MacFarlane et al., 1997; Pan et al., 1997a;
recruited to TRAIL-R1 and TRAIL-R2 independently of Schneider et al., 1997a; Screaton et al., 1997; Sheridan
each other. FADD/MORT1- and caspase-8-deficient et al., 1997; Walczak et al., 1997), TRAIL-R3 (DcR1/TRID/
Jurkat cells expressing only TRAIL-R2 were resistant LIT) (Degli-Esposti et al., 1997a; Pan et al., 1997a;
to TRAIL-induced apoptosis. Thus, FADD/MORT1 and Schneider et al., 1997a; Sheridan et al., 1997; Mongkol-
caspase-8 are essential for apoptosis induction via sapaya et al., 1998), TRAIL-R4 (DcR2/TRUNDD) (Degli-
TRAIL-R2. Esposti et al., 1997b; Marsters et al., 1997; Pan et al.,
1998), and Osteoprotegerin (OPG) (Emery et al., 1998).
TRAIL-R1 and TRAIL-R2 contain an intracellular DD nec-
Introduction essary for apoptosis induction upon TRAIL-mediated
receptor ligation. In contrast, neither TRAIL-R3 nor
Apoptosis is an essential process during the develop- TRAIL-R4 can mediate apoptosis due to complete or
ment of the immune system and for the maintenance partial absence of an intracellular DD, respectively. OPG
of T and B cell homeostasis. Two apoptosis-inducing is a soluble receptor reported to bind OPG ligand (OPGL/
members of the tumor necrosis factor (TNF) family, TNF RANKL/TRANCE/ODF) and TRAIL (Emery et al., 1998).
and CD95 ligand (CD95L/FasL/APO-1L), are involved in The biochemical events leading to apoptosis induc-
various immunological processes. These include inflam- tion via TNF and CD95 have been analyzed in detail.
mation, activation-induced T and B cell death, immune Cross-linking of CD95 leads to the formation of a death-
privilege, tumor evasion from the immune system, auto- inducing signaling complex (DISC) (Kischkel et al., 1995).
immunity, and AIDS (Nagata, 1997; Krammer, 1999; Wal- The death adaptor protein FADD/MORT1 (Boldin et al.,
lach et al., 1999). In addition, TNF and CD95L have been 1995; Chinnaiyan et al., 1995) and the proteolytic enzyme
shown to kill various tumor cell lines in vitro. TNF and caspase-8 (Boldin et al., 1996; Muzio et al., 1996) are
CD95L induce apoptosis upon binding to their cognate recruited to the CD95 DISC (Kischkel et al., 1995). In a
receptors capable of transmitting a caspase-activating homotypic interaction, the DD of FADD/MORT1 binds
to the DD of CD95. The death effector domain (DED) of
FADD/MORT1 in turn interacts with the DED of pro-k To whom correspondence should be addressed (e-mail: h.walczak@
dkfz.de). caspase-8 and thereby recruits this proenzyme to the
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CD95 DISC (Medema et al., 1997). Pro-caspase-8 is pro- show that FADD/MORT1 and caspase-8 are essential for
teolytically cleaved and thereby activated at the DISC. TRAIL-R2-mediated apoptosis.
Activated caspase-8 then initiates the apoptosis execut-
ing caspase cascade (Peter et al., 1999). Results
TNF induces apoptosis by cross-linking of its DD-con-
taining receptor TNF-R1 (p55). Ligand-induced cross- BL60, BJAB, and CEM Cells Are Susceptible
linking of TNF-R1 leads to the recruitment of TRADD to TRAIL-R1- and TRAIL-R2-Induced
and RIP to the DD of the receptor. FADD/MORT1 is Apoptosis, whereas Jurkat Cells
recruited to the TNF-R1 DISC via TRADD. In analogy to Express Only Functional TRAIL-R2
the CD95 system, FADD/MORT1 then recruits caspase-8 In order to dissect the apoptosis-inducing events imme-
to the TNF-R1 DISC by homotypic interaction of their diately following receptor stimulation by TRAIL in
respective DEDs resulting in activation of caspase-8 and lymphoid cells, we chose the human B cell lines BL60
apoptosis. Signals emanating from RIP and TRADD- and BJAB and the human T cell lines CEM and Jurkat
recruited TRAF2 result in activation of the NF-kB and as model systems. We characterized these cell lines by
Jun kinase pathways, respectively. These gene-induc- determination of TRAIL sensitivity, analysis of the time
tive events are responsible for the inflammatory pro- course of caspase-8 activation, and their TRAIL receptor
cesses associated with triggering of TNF-R1 (Wallach expression profile. We then analyzed the functionality
et al., 1999). of TRAIL-R1 and TRAIL-R2 signaling separately. All four
Given its implication in various immunological pro- cell lines were susceptible to LZ-TRAIL-induced apopto-
cesses, it is important to understand the biochemical sis (Figure 1A). In accordance with studies on non-
mechanism of initiation of TRAIL-induced apoptosis. So lymphoid cell lines (Griffith et al., 1998; Leverkus et al.,
far, this mechanism was addressed in a number of over- 2000), stimulation of BL60, BJAB, CEM, and Jurkat cells
expression studies examining the role of different known with LZ-TRAIL led to early cleavage and activation of
apoptosis signaling proteins. In some overexpression caspase-8 (Figure 1B) prior to cleavage of caspase-3
systems, dominant-negative FADD/MORT1 (FADD-DN) and PARP (data not shown). This supports an initiating
inhibited TRAIL-induced apoptosis (Chaudhary et al., role for caspase-8 during TRAIL-induced apoptosis also
1997; Schneider et al., 1997b; Walczak et al., 1997; Wa- in lymphoid cells. While BL60, BJAB, and CEM cells
jant et al., 1998). In other studies, FADD-DN overexpres- expressed both apoptosis-inducing TRAIL receptors,
sion did not prevent TRAIL-induced apoptosis (MacFar- only TRAIL-R2 was present on the surface of Jurkat
lane et al., 1997; Pan et al., 1997a, 1997b; Sheridan cells (Figure 1C, top panels). TRAIL-R3 and TRAIL-R4
et al., 1997). Coimmunoprecipitations of overexpressed were not detectable on the surface of these cell lines
cytoplasmic domains of TRAIL-R1 or TRAIL-R2 with (Figure 1C, bottom panels).
FADD/MORT1 supported a role for FADD/MORT1 in We next analyzed whether TRAIL-R1 and/or TRAIL-
TRAIL-induced apoptosis (Chaudhary et al., 1997; R2 were functionally expressed. After preincubation with
Schneider et al., 1997b). Yet, opposite results were ob- soluble blocking monoclonal antibodies (mAbs) against
tained in another study, as FADD/MORT1 was not coim- TRAIL-R1, TRAIL-R2, or a combination thereof, we
munoprecipitated with overexpressed TRAIL-R2 but treated the different cells with LZ-TRAIL (Figure 1D).
only with CD95 (MacFarlane et al., 1997). Murine embry- While the combination of TRAIL-R1- and TRAIL-R2-
onic fibroblasts (MEF) from FADD/MORT1-deficient specific mAbs inhibited TRAIL-induced apoptosis in all
mice underwent apoptosis upon overexpression of hu- four cell lines, preincubation with anti-TRAIL-R2 alone
man TRAIL-R1 (DR4) (Yeh et al., 1998). Thus, the role of
blocked TRAIL-induced apoptosis only in Jurkat cells.
FADD/MORT1 in TRAIL-induced apoptosis is still un-
Preincubation with blocking anti-TRAIL-R1 alone did not
clear.
inhibit TRAIL-induced apoptosis in any of the cell linesThe identity of the caspase(s) involved in the initiation
tested. Thus, BL60, BJAB, and CEM cells are suscepti-of TRAIL-mediated apoptosis is also controversial. Un-
ble to apoptosis mediated by ligand-induced cross-link-der native conditions, early cleavage of caspase-8 has
ing of either TRAIL-R1 or TRAIL-R2, whereas Jurkat cellsbeen observed following TRAIL stimulation (Griffith et
can only be killed via TRAIL-induced cross-linking ofal., 1998; Leverkus et al., 2000). Yet, overexpression
TRAIL-R2. These data show that these antibodies arestudies with dominant-negative forms of caspase-8
suitable for differential analysis of the individual proteinand -10 either suggested caspase-10 alone (Pan et al.,
complexes formed upon TRAIL-mediated cross-linking1997a) or a combination of caspase-8 and -10 (MacFar-
of the two different apoptosis-inducing TRAIL receptorslane et al., 1997) as initiator caspase(s) during TRAIL-
under native conditions.induced apoptosis. In addition, TRAIL resistance of ma-
ture DC and activated peripheral T cells from ALPS II
TRAIL-Dependent Recruitment of Caspase-8patients was suggested to be due to mutated nonfunc-
and FADD/MORT1 to the TRAIL DISCtional caspase-10 and to be causative for the disease
in BL60 Cells(Wang et al., 1999).
The active caspase-8 subunit p18 could be detectedTo dissect the molecular mechanisms of TRAIL-
as early as 15 min after TRAIL stimulation (Figure 1B),induced apoptosis initiation, we differentially analyzed
suggesting that caspase-8 might be the caspase re-the native TRAIL-R1 and TRAIL-R2 signaling complexes
sponsible for initiation of TRAIL-induced apoptosis. Theinduced upon TRAIL stimulation of sensitive target cells.
native protein complex that initiates TRAIL-inducedOur data indicate that, independently of each other,
apoptosis was analyzed for presence of the various sig-both TRAIL-R1 and TRAIL-R2 recruit FADD/MORT1 and
caspase-8 in a ligand-dependent fashion. In addition, we naling proteins that have been suggested to play a role at
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Figure 1. Analysis of Kinetics of TRAIL-Induced Apoptosis, Caspase-8 Cleavage, Receptor Expression Profile, and Functional Expression of
TRAIL-R1 and TRAIL-R2 in BL60, BJAB, CEM, and Jurkat Cells
(A and B) Cells were stimulated with 1 mg/ml LZ-TRAIL for the indicated time periods followed by analysis of percentage of cells with subdiploid
DNA content (A) and Western blot analysis of caspase-8 (p55/53) and its p18 cleavage product (B).
(C) FACS analysis of surface expression of TRAIL-R1 (upper panels, solid lines); TRAIL-R2 (upper panels, solid bold lines); TRAIL-R3 (lower
panels, solid lines); and TRAIL-R4 (lower panels, solid bold lines) as compared to an isotype-matched control mIgG1 mAb (dashed lines).
(D) Identification of TRAIL-R1- and TRAIL-R2-inhibiting mAbs. Cells were treated with 100 ng/ml LZ-TRAIL after 30 min preincubation with or
without blocking TRAIL-R1- and/or TRAIL-R2-specific mAbs at the indicated concentrations. The percentage of cell death was determined
by FSC/SSC analysis and plotted against the concentration of mAbs specific for TRAIL-R1 (closed circle), TRAIL-R2 (closed square), or both
apoptosis-inducing TRAIL receptors (closed triangle). Percentage of specific cell death was calculated as follows: 100 3 (% experimental
cell death 2 % spontaneous cell death)/(100 2 % spontaneous cell death). Spontaneous cell death was below 10% in all samples. One of
four representative experiments is shown.
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We conclude that TRAIL stimulation leads to the forma-
tion of an apoptosis-initiating protein complex, the
TRAIL DISC. FADD/MORT1, caspase-8, and the apopto-
sis-inducing TRAIL receptors, TRAIL-R1 and TRAIL-R2,
are integral components of this signaling complex. How-
ever, although prominently present in the lysates of BL60
cells, we could not detect caspase-10, RIP, and TRADD
associated with the TRAIL DISC at any time point ana-
lyzed (Figure 2, bottom panels).
FADD/MORT1 and Caspase-8 Form Part of the TRAIL
DISC in Various Lymphoid Cell Lines
We next studied whether FADD/MORT1 and caspase-8
recruitment to the TRAIL DISC can also be observed in
other cell lines that express both apoptosis-inducing
TRAIL receptors. Therefore, we compared the formation
of the TRAIL DISC in BL60 cells with the BJAB and CEM
TRAIL DISC. We incubated the cells for 20 min in the
presence or absence of Bio-LZ-TRAIL before analyzing
the proteins complexed with the biotinylated ligand.
TRAIL-R1 and TRAIL-R2 associated with Bio-LZ-TRAIL
in BJAB and CEM cells, and both FADD/MORT1 and
caspase-8 were recruited to the TRAIL DISC (Figure 3).
This association was stimulation dependent, since Bio-
LZ-TRAIL added after cell lysis precipitated the nonstim-
ulated receptors but not caspase-8 and FADD/MORT1.
Thus, these two signaling proteins, previously identified
as integral components of the native CD95 DISC (Kisch-
kel et al., 1995; Muzio et al., 1996), also form part of the
native TRAIL DISC in various cell lines.Figure 2. Kinetics of DISC Assembly in BL60 Cells
Jurkat cells only express TRAIL-R2 on their surfaceBL60 cells were either stimulated with 1 mg/ml biotinylated LZ-TRAIL
(Bio-LZ-TRAIL) for the indicated time periods or left untreated (2) (Figure 1C). Thus, Jurkat cells served to test whether
before cell lysis. Bio-LZ-TRAIL (1 mg/ml) was added to the lysates cross-linking of TRAIL-R2 in the absence of TRAIL-R1
in the untreated control. Bio-LZ-TRAIL-bound protein complexes may also lead to recruitment of FADD/MORT1 and
were analyzed by SDS-PAGE and Western blot following affinity
caspase-8. Stimulation of Jurkat cells with Bio-LZ-TRAILprecipitation with Streptavidin beads. Lysates prepared from BL60
induced recruitment of TRAIL-R2, caspase-8, and FADD/cells (Lys.) are shown as positive controls for caspase-10, RIP, and
MORT1 in the absence of TRAIL-R1 (Figure 3). UnderTRADD antibodies. The upper doublet band detected by the TRAIL-
R2 antibody corresponds to the two different splicing variants re- nonstimulatory conditions, only TRAIL-R2 was bound
ported (Screaton et al., 1997), while the lower doublet likely repre- to TRAIL, indicating that recruitment of FADD/MORT1
sents proteolytically processed forms of the the two TRAIL-R2 and caspase-8 to TRAIL-R2 is dependent on TRAIL-
variants (Walczak et al., 1997).
induced cross-linking of TRAIL-R2 on intact Jurkat cells.
Thus, homomeric TRAIL-R2 complexes are sufficient
for recruitment of FADD/MORT1 and caspase-8 in thethe onset of TRAIL-induced apoptosis (Figure 2). BL60
absence of TRAIL-R1.cells were incubated either in the absence or presence
of biotinylated LZ-TRAIL (Bio-LZ-TRAIL) for various time
periods. Both TRAIL-R1 and TRAIL-R2 were precipitated Homomeric TRAIL-R1 and TRAIL-R2 DISCs Recruit
FADD/MORT1 and Caspase-8 in BL60 Cellswith Bio-LZ-TRAIL already after 15 s of stimulation.
When analyzing the precipitated protein complex for the Since both apoptosis-inducing TRAIL receptors associ-
ated with TRAIL upon stimulation, FADD/MORT1 andpresence of caspase-8 and FADD/MORT1, we found
that both signaling proteins were recruited as early as caspase-8 might have been recruited to homomeric
TRAIL-R1, homomeric TRAIL-R2, or heteromeric com-15 s to 1 min after stimulation with Bio-LZ-TRAIL. In
addition, cleavage fragments of caspase-8 (p43/41), in- plexes containing TRAIL-R1 and TRAIL-R2. To differen-
tiate between the proteins associated with homomericdicative of activation of the proform of this enzyme (p55/
53), were detectable within 1±5 min of stimulation. In TRAIL-R1 and TRAIL-R2 DISC, respectively, we stimu-
lated the two receptors separately. This was achievedcontrast, caspase-8 and FADD/MORT1 did not associ-
ate with nonstimulated TRAIL receptors that were pre- by preincubating BL60 cells in the presence or absence
of blocking mAbs against TRAIL-R1 and TRAIL-R2, re-cipitated with Bio-LZ-TRAIL from the lysates of mock-
treated cells (Figure 2, left lane). Thus, recruitment of spectively, before stimulation with Bio-LZ-TRAIL (Figure
4, odd numbered lanes). In the unstimulated controlsFADD/MORT1 and caspase-8 was dependent on ligand-
induced receptor cross-linking. The amount of FADD/ (Figure 4, even numbered lanes), Bio-LZ-TRAIL added
after cell lysis could precipitate not only cell surface±MORT1 and caspase-8 recruited to the TRAIL receptors
increased in a time-dependent manner reaching maxi- bound but also intracellularly stored TRAIL-R1 and
TRAIL-R2, a finding recently described in melanomamum levels between 5 min and 20 min of stimulation.
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Figure 3. TRAIL DISC Analysis in BJAB,
CEM, and Jurkat Cells
BJAB, CEM, and Jurkat cells were left un-
treated or were treated for 20 min with 1 mg/
ml Bio-LZ-TRAIL before cell lysis. Bio-LZ-
TRAIL (1 mg/ml) was added to lysates from
unstimulated cells for precipitation of unstim-
ulated TRAIL receptors. Bio-LZ-TRAIL-bound
protein complexes were analyzed for pres-
ence of TRAIL-R1, TRAIL-R2, FADD/MORT1,
and caspase-8 by SDS-PAGE and Western
blot analysis following affinity precipitation
from the lysates with Streptavidin beads.
cells (Zhang et al., 2000). Western blot analysis revealed It is noteworthy that higher amounts of TRAIL-R1 and
TRAIL-R2 were detected in the control precipitate whenthat in the presence of TRAIL-R2 blocking mAb only
TRAIL-R1 was precipitated upon stimulation with Bio- compared to the stimulated condition (Figure 4, lanes
1 and 2). In addition, although antibody blockage beforeLZ-TRAIL (Figure 4, lane 3, top two panels) and vice
versa (Figure 4, lane 5, top two panels). Thus, both ho- stimulation completely inhibited precipitation of the
blocked receptor (Figure 4, lanes 3, 5, and 7), significantmomeric TRAIL-R1 and TRAIL-R2 DISCs were formed
upon stimulation with Bio-LZ-TRAIL. amounts of TRAIL-R1 and TRAIL-R2 were precipitated
in the unstimulated controls (Figure 4, lanes 4, 6, and
8). The incomplete blockage observed under nonstimu-
latory conditions indicates that, similar to melanoma
cells (Zhang et al., 2000), also BL60 cells contain sub-
stantial intracellular amounts of TRAIL-R1 and, to a
lesser extent, TRAIL-R2.
Stimulated homomeric TRAIL-R1 and TRAIL-R2 re-
cruited pro-caspase-8 (p55/53), cleavage intermediates
of caspase-8 (p43/41), and FADD/MORT1 (Figure 4,
lanes 3 and 5). This recruitment was dependent upon
ligand stimulation of TRAIL receptors on intact cells
since caspase-8 and FADD/MORT1 were not bound to
unstimulated TRAIL receptors (Figure 4, lanes 2, 4, 6, and
8). In addition, no other FADD/MORT1 and caspase-8
binding TRAIL receptors were present on BL60 cells
as concomitant blockage of TRAIL-R1 and TRAIL-R2
resulted in reduction of ligand-induced precipitation of
caspase-8 and FADD/MORT1 to background levels (Fig-
ure 4, lane 7). Thus, FADD/MORT1 and caspase-8 are
integral components of both the native homomericFigure 4. TRAIL Stimulation Induces Recruitment of FADD/MORT1
TRAIL-R1 DISC and the native homomeric TRAIL-R2and Caspase-8 to Homomeric TRAIL-R1 and TRAIL-R2 DISCs in
DISC in BL60 cells.BL60 Cells
After 30 min preincubation with 10 mg/ml blocking TRAIL-R1- and/
or TRAIL-R2-specific mAbs, cells were either stimulated with 1 mg/
FADD/MORT1 and Caspase-8 Are Essential forml Bio-LZ-TRAIL (1) for 20 min or left untreated (2) before cell lysis.
Bio-LZ-TRAIL (1 mg/ml) was added to the unstimulated samples for TRAIL-R2-Induced Apoptosis in Jurkat Cells
precipitation of unstimulated TRAIL receptors from lysates. Bio- The mere presence of a protein in the DISC does not
LZ-TRAIL-bound protein complexes were analyzed for presence of imply functional importance at the initiation of apopto-
TRAIL-R1, TRAIL-R2, FADD/MORT1, and caspase-8 by SDS-PAGE sis. Other proteins have been shown to associate with
and Western blot analysis following affinity precipitation from the
CD95 or TNF-R1 (Krammer, 1999; Wallach et al., 1999).lysates with streptavidin beads. After the longer exposure times
However, for the CD95 system, an essential functionnecessary to reveal the p43/41 forms of caspase-8, background
levels of caspase-8 can be seen in some unstimulated controls. could so far only be attributed to FADD/MORT1 and
Immunity
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Figure 5. FADD/MORT1 and Caspase-8 Are Necessary for TRAIL-R2-Induced Apoptosis
(A) Western Blot analysis for expression levels of FADD/MORT1, caspase-8, and caspase-3 in Jurkat A3, FADD/MORT1def, and caspase-8def
Jurkat cells. Migration positions of the detected proteins are indicated.
(B) FACS analysis of surface expression of TRAIL-R1 (upper panels, solid lines); TRAIL-R2 (upper panels, solid bold lines); TRAIL-R3 (lower
panels, solid lines); and TRAIL-R4 (lower panels, solid bold lines) as compared to an isotype-matched control mIgG1 mAb (dashed lines) on
Jurkat A3, FADDdef, and casp-8def cells.
(C) Jurkat A3 (closed circle), FADDdef (closed square), and casp-8def (closed triangle) cells were treated with the indicated concentrations of
LZ-TRAIL or were left untreated. Cell death was determined 12 hr after stimulation. Percentage of specific cell death was calculated as follows:
100 3 (% experimental cell death 2 % spontaneous cell death)/(100 2 % spontaneous cell death). Spontaneous cell death was below 10%
in all samples. All data points are the mean (6 SD) of six independent experiments.
(D) Jurkat A3, FADDdef, and casp-8def cells were transfected with an expression plasmid coding for a spectrin±GFP fusion protein (Kalejta et
al., 1997) together with an expression plasmid coding for the respective missing signaling component or together with empty vector in the
controls. Cells were incubated for 10 hr in the absence (open bars) or presence (closed bars) of 1 mg/ml LZ-TRAIL before cell death was
determined by FSC/SSC analysis in the GFP-positive cell population. Mean 6 SD of two independent experiments is shown.
caspase-8 as cells deficient for one of these two signal- (Figure 5B). In order to determine whether caspase-8
and FADD/MORT1 are necessary for TRAIL-R2-induceding proteins were resistant to CD95-mediated apopto-
sis. In addition to experiments with cells from mice defi- apoptosis in Jurkat cells, we treated FADDdef, casp-8def,
and Jurkat A3 control cells with LZ-TRAIL. Both thecient for FADD/MORT1 (Yeh et al., 1998; Zhang et al.,
1998) or caspase-8 (Varfolomeev et al., 1998) that FADDdef and casp-8def Jurkat cells were resistant to
TRAIL-induced apoptosis, while Jurkat A3 cells under-showed the requirement of these two signaling proteins,
respectively, it was shown that Jurkat cells deficient for went TRAIL-induced apoptosis in a dose-dependent
manner (Figure 5C).either one of these two proteins did not undergo CD95-
mediated apoptosis (Juo et al., 1998, 1999). These FADD/MORT1 and caspase-8 deficiency do not nec-
essarily constitute the only defects of these mutatedFADD/MORT1-deficient (FADDdef) and caspase-8-defi-
cient (casp-8def) Jurkat cells expressed normal levels cell lines. Therefore, we tested whether ectopic expres-
sion of FADD/MORT1 or caspase-8 resensitized the re-of caspase-3 but showed the expected deficiencies in
FADD/MORT1 and caspase-8 expression, respectively spective Jurkat clones for TRAIL-induced apoptosis.
While Jurkat A3 cells transfected with vector control(Figure 5A). In addition, the TRAIL receptor surface ex-
pression pattern of the deficient clones was identical to were killed by LZ-TRAIL, both Jurkat FADDdef and Jurkat
casp-8def remained TRAIL resistant when transfectedthat of Jurkat A3 control cells as TRAIL-R2 was ex-
pressed while TRAIL-R1, -R3, and -R4 were not present with vector alone. However, reconstitution of the miss-
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ing protein resensitized both cell lines for TRAIL-induced composition, the concept that caspase-10 and not cas-
pase-8 initiates TRAIL-induced apoptosis may not beapoptosis (Figure 5D). Since TRAIL resistance was over-
generally applicable.come by reexpression of FADD/MORT1 in Jurkat-FADDdef
Other adaptors like RIP and TRADD, although promi-and by reexpression of caspase-8 in the caspase-8def
nently present in the cell lysates, could not be detectedJurkat cells, TRAIL resistance was due to deficiency in
in the BL60 TRAIL DISC (Figure 2). Although we cannotthe respective signaling proteins. Therefore, we con-
rule out that these proteins may be associated as minorclude that FADD/MORT1 and caspase-8 are essential
components or in a more transient fashion than FADD/for TRAIL-R2-induced apoptosis and cannot be substi-
MORT1 and caspase-8, they are probably less importanttuted for by other endogenous proteins in Jurkat cells.
for the initiation of TRAIL-induced apoptosis. In the case
of TNF-R1 signaling, RIP and TRADD association haveDiscussion
been shown to activate the gene inductive JNK and NF-
kB pathways (Wallach et al., 1999). As we have onlyThus far, it has been controversial whether the adaptor
investigated TRAIL-sensitive cells, other proteins in-protein FADD/MORT1 and caspase-8 play a key role in
cluding RIP and TRADD, reported to associate withTRAIL-induced apoptosis (Ashkenazi and Dixit, 1999).
TRAIL receptors upon overepression, may serve anti-Our data demonstrate that endogenous FADD/MORT1
rather than proapoptotic functions. Analysis of TRAIL-and caspase-8 are recruited to the native TRAIL DISC
resistant cells will provide further insight into thesewithin seconds following stimulation with TRAIL. Subse-
mechanisms.quently, caspase-8 is cleaved and DNA fragmentation
So far, it was unclear whether TRAIL-induced apopto-typical for apoptosis is observed in BL60, BJAB, CEM,
sis may be differentially regulated by the triggering ofand Jurkat cells. These data imply that FADD/MORT1
the two different apoptosis-inducing TRAIL receptors.and caspase-8 are likely to play an important role during
Here we show that TRAIL-induced cross-linking of eitherTRAIL-induced apoptosis.
TRAIL-R1 or TRAIL-R2 leads to the recruitment of bothHowever, FADD/MORT1-deficient murine embryonic
FADD/MORT1 and caspase-8 to the individual receptor-fibroblasts (MEF) were shown to undergo apoptosis
specific DISCs. Apart from the homomeric receptor com-upon overexpression of human TRAIL-R1 (Yeh et al.,
plexes, heteromeric complexes consisting of TRAIL-R11998). In the light of our data showing essential recruit-
and TRAIL-R2 also may exist. We cannot exclude thatment of FADD/MORT1 and caspase-8 to the TRAIL-
these complexes may signal apoptosis via an additionalR2 DISC, there are three possible explanations for this
pathway different from the FADD/MORT1 and caspase-8finding by Yeh and colleagues. TRAIL-R1-induced apo-
involving pathway. However, these complexes and theirptosis in MEFs could be due to overexpression-related
associated signaling proteins would be part of the TRAILunspecific recruitment of an adaptor protein different
DISC in BL60 cells. Since we did not detect TRADD,from FADD/MORT1. Alternatively, cell type±specific dif-
RIP, and caspase-10 in the BL60 TRAIL DISC (Figureferences between the lymphoid cell lines studied here
2), it is unlikely that these proteins associate with hetero-and MEFs could be responsible for the differential re-
meric complexes and may, thus, be common mediators
sults. The most attractive explanation, however, is that
of TRAIL-induced apoptosis.
TRAIL-R1 and TRAIL-R2 may be differentially regulated.
Finally, we could show that TRAIL-resistant FADD/
TRAIL-R1-induced apoptosis may, therefore, use an ad-
MORT1- and caspase-8-deficient Jurkat cells express-
ditional, as of yet unidentified, FADD/MORT1-indepen- ing TRAIL-R2 regained TRAIL sensitivity upon reexpres-
dent apoptotic mechanism (Yeh et al., 1998) apart from sion of these two proteins. Thus, caspase-8 and FADD/
the FADD/MORT1 involving pathway (Figure 4), whereas MORT1 are essential for TRAIL-R2-induced apoptosis,
TRAIL-R2-induced apoptosis may be entirely depen- as they are for CD95-mediated apoptosis (Juo et al.,
dent on FADD/MORT1 (Figures 3, 4, and 5). Thus, the 1998, 1999; Varfolomeev et al., 1998; Yeh et al., 1998;
observed coexpression of the two apoptosis-inducing Zhang et al., 1998). These data clearly establish the
TRAIL receptors on certain cell types would allow for importance of FADD/MORT1 and caspase-8 in TRAIL-
fine-tuned regulation of TRAIL-induced apoptosis. induced apoptosis. FADD/MORT1 and caspase-8 have
DN-caspase-10 and not DN-caspase-8 (Pan et al., previously been shown to be implicated in apoptosis
1997a) or both DN-caspase-10 and DN-caspase-8 (Mac- induction via CD95, TNF-R1, and TRAMP (Ashkenazi
Farlane et al., 1997) were reported to associate with and Dixit, 1999; Krammer, 1999). Thus, the recruitment
overexpressed TRAIL-R1 and TRAIL-R2 and to inhibit of endogenous FADD/MORT1 and caspase-8 to the na-
apoptosis induced by overexpression of these two re- tive TRAIL-R1 and TRAIL-R2 provides evidence that
ceptors. In addition, caspase-10 was suggested to play these two proteins play a central role in death receptor±
a role in TRAIL-induced apoptosis of mature DC and mediated apoptosis.
peripheral activated T cells. Deletion of these cells was There is an apparent discrepancy between our data
reported to be inhibited in ALPS II patients carrying on the composition of the native TRAIL DISC and other
mutated caspase-10, which supposedly caused TRAIL reports showing no association of FADD/MORT1 with
resistance of T cells and DCs in these patients (Wang TRAIL-R1 or TRAIL-R2. In addition, in some studies
et al., 1999). However, recently one of the caspase-10 overexpression of FADD-DN failed to inhibit apoptosis
variants was identified as a common polymorphism in induced by TRAIL or overexpressed TRAIL-R1 or TRAIL-
the Danish population with an allele frequency of 6.8% R2. While our studies were performed in cell lines ex-
(Gronbaek et al., 2000). These data cast doubt on the role pressing native levels of the respective proteins, all pre-
of caspase-10 mutations as the sole causative factor for vious experiments were performed under conditions
where at least one of the putatively interacting proteinsALPS II. In the light of our data on native TRAIL DISC
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M413 anti-TRAIL-R2, M430 anti-TRAIL-R3, M444 anti-TRAIL-R4) orwas overexpressed. This overexpression of DD/DED
control mIgG1 followed by biotinylated secondary goat anti-mousecontaining proteins might result in nonspecific aggrega-
antibodies (Southern Biotechnology Associates) and Streptavidin-tion. In addition, the homeostasis of different interacting
PE (Pharmingen, Hamburg, Germany). Surface staining was deter-
proteins and, thus, assembly of the signaling complexes mined on a FACScan cytometer (Becton Dickinson, Heidelberg, Ger-
could be disturbed. many). Specificity of the respective anti-TRAIL-R mAbs used here
was determined by staining of TRAIL-R1 to TRAIL-R4 on CV1/EBNAAs shown in Figure 2, caspase-8 and FADD/MORT1
cells transfected with expression vectors coding for the individualcoprecipitate only with stimulated TRAIL receptors. Sev-
surface-bound TRAIL receptors (data not shown).eral of the previous studies relied on coprecipitation
of proteins with overexpressed receptors without prior
ligand-induced cross-linking. Although overexpression Quantitation of Apoptotic Cell Death
of TRAIL receptors induces apoptosis, this does not As a direct measurement of apoptotic cell death, DNA fragmentation
was quantified essentially as described (Nicoletti et al., 1991).necessarily mimick ligand-induced receptor oligomer-
Briefly, 2.5 3 105 cells were incubated in 24-well plates (Costar,ization. In conclusion, it seems that overexpression
Cambridge, MA) with or without apoptotic stimuli in 0.5 ml mediumstudies alone are not sufficient to define molecular inter-
at 378C. Cells were collected by centrifugation at 600 3 g for 10
actions in apoptosis signaling. min at 48C, washed twice with PBS, and then resuspended in 100 ml
TRAIL-induced apoptosis seems to utilize a pathway lysis solution containing 0.1% (v/v) Triton X-100, 0.1% (w/v) sodium
similar to the one used by CD95 (Krammer, 1999; Peter et citrate, and 50 mg/ml propidium iodide (PI). Apoptosis was quantita-
tively determined by flow cytometry after incubation at 48C in theal., 1999). Yet, most normal cells are resistant to TRAIL,
dark for at least 24 hr as cells containing nuclei with subdiploid DNAwhereas CD95 agonists have been shown to kill various
content. Alternatively, apoptosis was determined by a drop in thenormal cells (Nagata, 1997; Krammer, 1999) and, in con-
forward to sideward scatter (FSC/SSC) profile of apoptotic in com-
trast to TRAIL (Ashkenazi et al., 1999; Walczak et al., parison to living cells.
1999), are toxic upon systemic administration (Ogasa-
wara et al., 1993; Walczak et al., 1999). Thus, in addition
Preparation of Cell Lysatesto the similarities between the CD95 and TRAIL receptor
Cells were harvested by centrifugation at 300 3 g for 10 min atpathways, there must also be differences between them.
48C and washed twice with PBS, and lysates were prepared by
Studying TRAIL signaling in resistant cells will be likely to resuspending the resulting cell pellets in 100 ml lysis buffer per 1 3
give insight into the mechanisms that regulate sensitivity 107 cells (30 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10% Glycerol,
versus resistance to TRAIL-induced apoptosis. The 1% Triton X-100) supplemented with Complete protease inhibitors
(Roche Diagnostics, Mannheim, Germany) according to the manu-identification of the native TRAIL apoptosis-inducing
facturer's instructions. After 30 min incubation on ice, the lysatessignaling complex presented here provides the basis
were centrifuged once at 15,000 3 g at 48C to remove nuclei. Infor such analyses.
the case of lysate preparation for ligand affinity precipitations, an
intermediate centrifugation step (600 3 g for 15 min at 48C) was
Experimental Procedures added after lysis in order to remove cellular debris.
Cell Lines
The human B cell lines BL60 and BJAB and the human T cell lines Western Blot Analysis
CEM and Jurkat were maintained in RPMI 1640 (GIBCO-BRL, Karls- For Western blot analysis, the resulting postnuclear supernatants
ruhe, Germany) containing 10% fetal calf serum (GIBCO-BRL). The or ligand affinity precipitates were supplemented with 2-fold con-
mutated Jurkat FADDdef, Jurkat casp-8def, and the Jurkat A3 control centrated standard reducing sample buffer (23 RSB). Subsequently,
cells were cultured as described elsewhere (Juo et al., 1998, 1999). lysate containing 20 mg of protein as determined by the BCA method
(Pierce, Rockford, IL) or proteins eluted from beads after ligand
Antibodies and Reagents affinity immunoprecipitation were separated on 4%±12% NuPage
Monoclonal antibodies (mAb) against FADD/MORT1, TRADD, RIP, Bis-Tris gradient gels (Novex, San Diego, CA) in MOPS buffer ac-
and caspase-3 were purchased from Transduction Laboratories cording to the manufacturer's instructions. After protein transfer
(San Diego, CA). Anti-caspase 10 mAb (Zytomed, Berlin, Germany) onto nitrocellulose membranes (Amersham Pharmacia Biotech,
was raised against the p17 subunit of caspase 10. The mAb anti- Freiburg, Germany) by electroblotting, membranes were blocked
FLICE C15 recognizes the p18 subunit of caspase-8 (Scaffidi et al., with 5% nonfat dry milk (NFDM) in PBS/Tween (PBS containing
1997), whereas the anti-caspase-3 mAb recognizes the p17 subunit 0.05% Tween-20) for at least 2 hr, washed with PBS/Tween, and
of caspase-3 but not the p12 subunit. Leucine zipper (LZ) ±TRAIL incubated in PBS/Tween containing 3% NFDM and primary antibod-
is a stable trimer of TRAIL and induces apoptosis upon binding to ies against caspase-3, caspase-10, FADD/MORT1, TRADD, RIP,
TRAIL-sensitive cells (Walczak et al., 1997). The antibodies specific TRAIL-R1 (M270 and M272), TRAIL-R2 (M414 and M415) (all at 1
for the different TRAIL receptors were described elsewhere (Griffith mg/ml), or caspase-8 (1:10-diluted C15 hybridoma supernatant
et al., 1999a). We used anti-TRAIL-R1 M272 and TRAIL-R2 M413 [Scaffidi et al., 1997]). Specificity of the respective anti-TRAIL-R
for FACS staining and anti-TRAIL-R1 M271 and anti-TRAIL-R2 M413 mAbs used here was determined by Western blot analysis of TRAIL-
for receptor blockade. Combinations of anti-TRAIL-R1 mAbs (M270 R1 to TRAIL-R4 in lysates prepared from CV1/EBNA cells trans-
and M272) or anti-TRAIL-R2 mAbs (M414 and M415) were used for fected with expression vectors coding for the individual TRAIL re-
Western blot detection of TRAIL-R1 and TRAIL-R2, respectively. ceptors (data not shown). After six washes for 5 min each in PBS/
Horseradish peroxidase (HRPO) ±conjugated goat anti-mouse IgG1, Tween, the blots were incubated with HRPO-conjugated isotype-
IgG2a, and IgG2b polyclonal antibodies (pAb) were obtained from specific secondary antibody diluted 1:20,000 in PBS/Tween. After
Southern Biotechnology Associates (Birmingham, AL). HRPO-goat washing six times for 5 min with PBS/Tween, the blots were devel-
anti-rat IgG was from Jackson ImmunoResearch (Dianova, Ham- oped by enhanced chemoluminescence (ECL) following the manu-
burg, Germany). All other chemicals used were of analytical grade facturer's protocol (Amersham Pharmacia Biotech). For stripping,
and purchased from Merck (Darmstadt, Germany) or Sigma Chemi- blots were either incubated for 30 min in a buffer containing 62.5
cal Co. (St. Louis, MO). mM Tris/HCl (pH 6.8), 2% SDS, and 100 mM b-mercaptoethanol at
608C or in 50 mM glycine HCl (pH 1.9) for 20 min at room temperature
when only secondary antibodies needed to be removed. Subse-FACS Analysis
Cells were incubated with mAbs of the same isotype (mIgG1) against quently, blots were washed six times for 10 min in PBS/Tween and
blocked again.the four surface-expressed TRAIL receptors (M272 anti-TRAIL-R1,
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Ligand Affinity Precipitation (1999). Safety and antitumor activity of recombinant soluble Apo2
ligand. J. Clin. Invest. 104, 155±162.We performed ligand affinity precipitations by using biotinylated
LZ-TRAIL (Bio-LZ-TRAIL) in combination with Streptavidin beads Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H.,
(Pierce). Bio-LZ-TRAIL was prepared by incubation of purified LZ- and Wallach, D. (1995). A novel protein that interacts with the death
TRAIL at 1 mg/ml with Sulfo-NHS-LC-Biotin at 1 mg/ml (Pierce) for domain of Fas/APO1 contains a sequence motif related to the death
1 hr on ice before the reaction was stopped by adding 1/10 volume domain. J. Biol. Chem. 270, 7795±7798.
of 1 M Tris-HCl at pH 7.5. Unincorporated biotin was removed from Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996).
Bio-LZ-TRAIL preparations by buffer exchange into 150 mM NaCl, Involvement of MACH, a novel MORT1/FADD-interacting protease,
30 mM HEPES (pH 7.5) on PD-10 columns (Amersham Pharmacia in Fas/APO-1- and TNF receptor-induced cell death. Cell 85,
Biotech). Protein preparations were checked for purity and incorpo- 803±815.
ration of biotin by SDS-PAGE. The biological activity of Bio-LZ-
Chaudhary, P.M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J.,TRAIL was determined by its apoptosis-inducing capacity and found
and Hood, L. (1997). Death receptor 5, a new member of the TNFRto be comparable to nonbiotinylated LZ-TRAIL.
family, and DR4 induce FADD-dependent apoptosis and activateFor ligand affinity precipitation, 3 3 108 cells were used per sam-
the NF-kB pathway. Immunity 7, 821±830.ple. Cells were washed twice with 50 ml RPMI medium at 378C and
Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995).subsequently incubated for the indicated time periods at 378C and
FADD, a novel death domain±containing protein, interacts with thea cell density of 1 3 108/ml in the presence of 1 mg/ml Bio-LZ-TRAIL
death domain of Fas and initiates apoptosis. Cell 81, 505±512.or, for the unstimulated control, in the absence of Bio-LZ-TRAIL. In
the case of differential TRAIL receptor DISC analysis, we preincu- Degli-Esposti, M.A., Smolak, P.J., Walczak, H., Waugh, J., Huang,
bated the cells with 10 mg/ml TRAIL-R1 and/or TRAIL-R2-blocking C.P., DuBose, R.F., Goodwin, R.G., and Smith, C.A. (1997a). Cloning
mAbs for 15 min before stimulation with Bio-LZ-TRAIL. DISC forma- and characterization of TRAIL-R3, a novel member of the emerging
tion was stopped by addition at least 15 volumes of ice-cold PBS. TRAIL receptor family. J. Exp. Med. 186, 1165±1170.
Cells were then washed twice with 50 ml ice-cold PBS before cell Degli-Esposti, M.A., Dougall, W.C., Smolak, P.J., Waugh, J.Y., Smith,
lysates were prepared by addition of 4.5 ml lysis buffer per 3 3 108 C.A., and Goodwin, R.G. (1997b). The novel receptor TRAIL-R4 in-
cells. The resulting protein complexes were precipitated from the duces NF-kB and protects against TRAIL-mediated apoptosis, yet
lysates by coincubation with 20 ml Streptavidin Beads (Pierce) for retains an incomplete death domain. Immunity 7, 813±820.
2±4 hr on an end-over-end shaker at 48C. For the precipitation of the
Emery, J.G., McDonnell, P., Burke, M.B., Deen, K.C., Lyn, S., Sil-nonstimulated receptors, Bio-LZ-TRAIL was added to the lysates
verman, C., Dul, E., Appelbaum, E.R., Eichman, C., DiPrinzio, R., etprepared from nonstimulated cells at 1 mg/ml to control for protein
al. (1998). Osteoprotegerin is a receptor for the cytotoxic ligandassociation to nonstimulated receptor(s). Ligand affinity precipitates
TRAIL. J. Biol. Chem. 273, 14363±14367.were washed four times with lysis buffer before the protein com-
Fanger, N.A., Maliszewski, C.R., Schooley, K., and Griffith, T.S.plexes were eluted from the beads by addition of 15 ml 23 standard
(1999). Human dendritic cells mediate cellular apoptosis via tumorreducing sample buffer. Subsequently, proteins were separated on
necrosis factor±related apoptosis-inducing ligand (TRAIL). J. Exp.SDS-PAGE before presence or absence of antigens was determined
Med. 190, 1155±1164.in the different precipitates by Western blot analysis.
Gliniak, B., and Le, T. (1999). Tumor necrosis factor±related apopto-
sis-inducing ligand's antitumor activity in vivo is enhanced by theTransfection and Complementation
chemotherapeutic agent CPT-11. Cancer Res. 59, 6153±6158.Jurkat A3 control, FADDdef, and FLICEdef cells were transfected es-
Griffith, T.S., Chin, W.A., Jackson, G.C., Lynch, D.H., and Kubin,sentially as described (Juo et al., 1998) with slight modifications. In
M.Z. (1998). Intracellular regulation of TRAIL-induced apoptosis inbrief, 6 3 106 cells were transfected with a total of 20 mg DNA by
human melanoma cells. J. Immunol. 161, 2833±2840.electroporation with an expression plasmid coding for a spectrin±
GFP fusion protein (Kalejta et al., 1997) together with an expression Griffith, T.S., Rauch, C.T., Smolak, P.J., Waugh, J.Y., Boiani, N.,
plasmid coding for the respective missing signaling component, or Lynch, D.H., Smith, C.A., Goodwin, R.G., and Kubin, M.Z. (1999a).
together with empty vector in the controls, at a ratio of 3 to 1 (0.4 Functional analysis of TRAIL receptors using monoclonal antibod-
cm cuvette, 250 V, 950 mF, Bio-Rad Gene-Pulser). The expression ies. J. Immunol. 162, 2597±2605.
plasmids pRSV-HA-FADD, pRSV-caspase-8, or empty control vec- Griffith, T.S., Wiley, S.R., Kubin, M.Z., Sedger, L.M., Maliszewski,
tor are described elsewhere (Juo et al., 1998, 1999). Cells were C.R., and Fanger, N.A. (1999b). Monocyte-mediated tumoricidal ac-
purified over a Ficoll gradient 1 hr after transfection in order to tivity via the tumor necrosis factor±related cytokine, TRAIL. J. Exp.
remove dead cells. After each transfection, half of the cells were Med. 189, 1343±1354.
either left untreated or stimulated with 1 mg/ml LZ-TRAIL. After 10 Gronbaek, K., Dalby, T., Zeuthen, J., Ralfkiaer, E., and Guidberg, P.
hr of incubation, apoptosis was quantified by FSC/SSC analysis of (2000). The V410I (G1228A) variant of the caspase-10 gene is a
the GFP-positive population on a FACSscan cytometer (Beckton common polymorphism of the Danish population. Blood 95, 2184±
Dickinson). 2185.
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